Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Fourquet

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Breast (Edinburgh, Scotland)|May 21, 2010
The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term resultsCyrus Chargari, Youlia M Kirova, Fatima Laki, et al.
Plos One|August 8, 2014
Epigenomic alterations in breast carcinoma from primary tumor to locoregional recurrencesMatahi Moarii, Alice Pinheiro, Brigitte Sigal-Zafrani, et al.
International Journal of Cancer|July 16, 2021
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Acta Oncologica (Stockholm, Sweden)|October 12, 2023
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centreLouis-Marie Sauvage, Pierre Loap, Jeremi Vu-Bezin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2009
Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapyYoulia M Kirova, Francois Campana, Alexia Savignoni, et al.
Journal of Neuro-Oncology|June 7, 2011
Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapyCiprian Chira, Julian Jacob, Najib Derhem, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2015
Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trialLouis Bazire, Isabelle Fromantin, Alhassane Diallo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2025
Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Marc-Henri Stern, et al.
Cancer Treatment Reviews|September 25, 2010
Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessmentCyrus Chargari, Krassen M Kirov, Marc A Bollet, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Breast (Edinburgh, Scotland)|May 21, 2010
The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term resultsCyrus Chargari, Youlia M Kirova, Fatima Laki, et al.
Plos One|August 8, 2014
Epigenomic alterations in breast carcinoma from primary tumor to locoregional recurrencesMatahi Moarii, Alice Pinheiro, Brigitte Sigal-Zafrani, et al.
International Journal of Cancer|July 16, 2021
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Acta Oncologica (Stockholm, Sweden)|October 12, 2023
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centreLouis-Marie Sauvage, Pierre Loap, Jeremi Vu-Bezin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2009
Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapyYoulia M Kirova, Francois Campana, Alexia Savignoni, et al.
Journal of Neuro-Oncology|June 7, 2011
Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapyCiprian Chira, Julian Jacob, Najib Derhem, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2015
Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trialLouis Bazire, Isabelle Fromantin, Alhassane Diallo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2025
Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Marc-Henri Stern, et al.
Cancer Treatment Reviews|September 25, 2010
Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessmentCyrus Chargari, Krassen M Kirov, Marc A Bollet, et al.
Pageof 17